Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis

Bone Marrow Transplantation volume 36, pages 115–121 (2005)Cite this article

Summary:

To evaluate the incidence, risk factors and prognosis for solid tumors after hematopoietic stem cell transplantation (HSCT) in Japan, 809 patients who had received HSCT between 1981 and 2000 were retrospectively analyzed. In all, 19 newly diagnosed secondary cancers were observed. The risk for cancer development was 2.8 times as high as that for expected cases. The cumulative incidence ratios at 5 and 10 years were 1.9 and 4.2%, respectively. The risk was significantly elevated for buccal cavity cancer (standard incidental ratio (SIR), 44.42: 95% confidence interval (CI) 17.86–91.51), esophageal cancer (SIR, 22.36: 95% CI 6.09–57.25), and cervical cancer (SIR, 8.58: 95% CI 1.04–31.01). Of 15 patients who developed solid cancers following allografting, 12 had chronic graft-versus-host disease (GVHD), and all 10 patients with squamous cell carcinoma of the buccal cavity or esophagus had chronic GVHD. On multivariate analysis, extensive chronic GVHD and age over 45 years at the time of transplantation were associated with a higher risk for solid cancers. In all, 17 patients received therapy for secondary cancers, nine of whom are still alive and the 5-year probability of survival from the diagnosis is 42.8%. Our data suggest that early detection of secondary cancers is very important in prolonging overall survival.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Curtis RE, Rowlings PA, Deeg HJ et al. Solid cancers after bone marrow transplantation. N Engl J Med 1997; 336: 897–904.

    Article  CAS  PubMed  Google Scholar 

  2. Witherspoon RP, Fisher LD, Schoch G et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 1989; 321: 784–789.

    Article  CAS  PubMed  Google Scholar 

  3. Deeg HJ, Socie G . Malignancies after hematopoietic stem cell transplantation: many questions, some answers. Blood 1998; 91: 1833–1844.

    CAS  PubMed  Google Scholar 

  4. Micallef IN, Lillington DM, Apostolidis J et al. Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies. J Clin Oncol 2000; 18: 947–955.

    Article  CAS  PubMed  Google Scholar 

  5. Curtis RE, Travis LB, Rowlings PA et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 1999; 94: 2208–2216.

    CAS  PubMed  Google Scholar 

  6. Bhatia S, Louie AD, Bhatia R et al. Solid cancers after bone marrow transplantation. J Clin Oncol 2001; 19: 464–471.

    Article  CAS  PubMed  Google Scholar 

  7. Baker KS, DeFor TE, Burns LJ et al. New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors. J Clin Oncol 2003; 21: 1352–1358.

    Article  PubMed  Google Scholar 

  8. Kolb HJ, Socie G, Duell T et al. Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group. Ann Intern Med 1999; 131: 738–744.

    Article  CAS  PubMed  Google Scholar 

  9. The Research Group for Population-based Cancer Registration in Japan. Cancer incidence and incidence rates in Japan in 1998: estimates based on data from 12 population-based cancer registries. Jpn J Clin Oncol 2003; 33: 241–245.

  10. The Research Group for Population-based Cancer Registration in Japan. Cancer incidence and incidence rates in Japan in 1997: estimates based on data from 12 population-based cancer registries. Jpn J Clin Oncol 2002; 32: 318–322.

  11. The Research Group for Population-based Cancer Registration in Japan. Cancer incidence and incidence rates in Japan in 1992–93: estimates based on data from seven population-based cancer registries. The Research Group for Population-based Cancer Registration in Japan. Jpn J Clin Oncol 1998; 28: 641–647.

  12. The Research Group for Population-based Cancer Registration in Japan. Cancer incidence in Japan, 1985–89: re-estimation based on data from eight population-based cancer registries. The Research Group for Population-based Cancer Registration in Japan. Jpn J Clin Oncol 1998; 28: 54–67.

  13. Esteve J, Benhamou E, Raymond L . Statistical methods in cancer research. Volume IV. Descriptive epidemiology. IARC Sci Publ 1994; 128: 1–302.

    Google Scholar 

  14. Krishnan A, Bhatia S, Slovak ML et al. Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors. Blood 2000; 95: 1588–1593.

    CAS  PubMed  Google Scholar 

  15. Milligan DW, Ruiz De Elvira MC, Kolb HJ et al. Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation. Br J Haematol 1999; 106: 1020–1026.

    Article  CAS  PubMed  Google Scholar 

  16. Socie G, Henry-Amar M, Cosset JM et al. Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia. Blood 1991; 78: 277–279.

    CAS  PubMed  Google Scholar 

  17. Socie G, Curtis RE, Deeg HJ et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol 2000; 18: 348–357.

    Article  CAS  PubMed  Google Scholar 

  18. Bhatia S, Ramsay NK, Steinbuch M et al. Malignant neoplasms following bone marrow transplantation. Blood 1996; 87: 3633–3639.

    CAS  PubMed  Google Scholar 

  19. Charles M . UNSCEAR report 2000: sources and effects of ionizing radiation. United Nations Scientific Comittee on the Effects of Atomic Radiation. J Radiol Prot 2001; 21: 83–86.

    Article  CAS  PubMed  Google Scholar 

  20. Neglia JP, Meadows AT, Robison LL et al. Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 1991; 325: 1330–1336.

    Article  CAS  PubMed  Google Scholar 

  21. Cohen A, Rovelli A, van Lint MT et al. Secondary thyroid carcinoma after allogeneic bone marrow transplantation during childhood. Bone Marrow Transplant 2001; 28: 1125–1128.

    Article  CAS  PubMed  Google Scholar 

  22. Bhatia S, Sather HN, Pabustan OB et al. Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. Blood 2002; 99: 4257–4264.

    Article  CAS  PubMed  Google Scholar 

  23. Hawkins MM, Wilson LM, Burton HS et al. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst 1996; 88: 270–278.

    Article  CAS  PubMed  Google Scholar 

  24. Tucker MA, D'Angio GJ, Boice Jr JD et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 1987; 317: 588–593.

    Article  CAS  PubMed  Google Scholar 

  25. Friedman DL, Leisenring W, Schwartz JL et al. Second malignant neoplasms following hematopoietic stem cell transplantation. Int J Hematol 2004; 79: 229–234.

    Article  PubMed  Google Scholar 

  26. Curtis RE, Metayer C, Rizzo JD et al. Impact of chronic GvHD therapy on the development of squamous cell cancers after hematopoietic stem cell transplantation: an international case–control study. Blood 2005; 105: 3802–3811.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Akpek G, Zahurak ML, Piantadosi S et al. Development of a prognostic model for grading chronic graft-versus-host disease. Blood 2001; 97: 1219–1226.

    Article  CAS  PubMed  Google Scholar 

  28. Rocha V, Franco RF, Porcher R et al. Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. Blood 2002; 100: 3908–3918.

    Article  CAS  PubMed  Google Scholar 

  29. Vittorio CC, Schiffman MH, Weinstock MA . Epidemiology of human papillomaviruses. Dermatol Clin 1995; 13: 561–574.

    Article  CAS  PubMed  Google Scholar 

  30. Sasadeusz J, Kelly H, Szer J et al. Abnormal cervical cytology in bone marrow transplant recipients. Bone Marrow Transplant 2001; 28: 393–397.

    Article  CAS  PubMed  Google Scholar 

  31. Gmeinhart B, Hinterberger W, Greinix HT et al. Anaplastic squamous cell carcinoma (SCC) in a patient with chronic cutaneous graft-versus-host disease (GVHD). Bone Marrow Transplant 1999; 23: 1197–1199.

    Article  CAS  PubMed  Google Scholar 

  32. Socie G, Scieux C, Gluckman E et al. Squamous cell carcinomas after allogeneic bone marrow transplantation for aplastic anemia: further evidence of a multistep process. Transplantation 1998; 66: 667–670.

    Article  CAS  PubMed  Google Scholar 

  33. Forrest DL, Nevill TJ, Naiman SC et al. Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis. Bone Marrow Transplant 2003; 32: 915–923.

    Article  CAS  PubMed  Google Scholar 

  34. Andre M, Henry-Amar M, Blaise D et al. Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease. Blood 1998; 92: 1933–1940.

    CAS  PubMed  Google Scholar 

  35. Socie G, Henry-Amar M, Devergie A et al. Poor clinical outcome of patients developing malignant solid tumors after bone marrow transplantation for severe aplastic anemia. Leukemia Lymphoma 1992; 7: 419–423.

    Article  CAS  PubMed  Google Scholar 

  36. Friedberg JW, Neuberg D, Stone RM et al. Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol 1999; 17: 3128–3135.

    Article  CAS  PubMed  Google Scholar 

  37. Favre-Schmuziger G, Hofer S, Passweg J et al. Treatment of solid tumors following allogeneic bone marrow transplantation. Bone Marrow Transplant 2000; 25: 895–898.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nagoya Blood and Marrow Transplantation Group (NBMTG), Nagoya, Japan

    K Shimada, T Yokozawa, Y Atsuta, A Kohno, F Maruyama, K Yano, H Taji, K Kitaori, S Goto, H Iida, Y Morishima, Y Kodera, T Naoe & Y Morishita

Authors
  1. K Shimada
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T Yokozawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y Atsuta
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Kohno
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F Maruyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K Yano
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H Taji
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. K Kitaori
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S Goto
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. H Iida
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Y Morishima
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Y Kodera
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. T Naoe
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Y Morishita
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K Shimada.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shimada, K., Yokozawa, T., Atsuta, Y. et al. Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis. Bone Marrow Transplant 36, 115–121 (2005). https://doi.org/10.1038/sj.bmt.1705020

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705020

Keywords

This article is cited by

Search

Advanced search

Quick links